Actress and Biden supporter Alyssa Milano tweeted recently:
Trump can make history as the first President to be impeached twice. I mean, if putting lives in danger by pushing a drug for personal gain during a pandemic isn’t impeachmable, we should just throw in the towel.
However, this line of attack is not exactly what it may seem at first glance once you dig into the math.
Donald Trump Jr. tweeted:
Strange that the New York Times would fail to mention this publicly disclosed information🙄 Instead they try to make it seem like he was self dealing because he was hopeful!
Trump’s personal stake in the malaria-drug maker Sanofi could be as small as $99
Marketwatch reports as President Donald Trump has persistently discussed the malaria drug hydroxychloroquine, critics have wondered about his motivation, given the drug’s far-from-certain performance on the global stage as a treatment for coronavirus, and the Food and Drug Administration’s refusal so far to approve it as a treatment for COVID-19.
The New York Times says Trump has a “small personal stake” in Sanofi, the French drug manufacturer that produces the drug.
The report doesn’t say how small, but it notes that his three family trusts have investments in a Dodge & Cox mutual fund whose largest holding is Sanofi. A fund that matches this description is the Dodge & Cox International Stock Fund DODFX, +0.65%, which at last check was 3.3% invested in Sanofi.
Trump’s 2019 financial-disclosure form lists stakes in Family Trusts 1, 2 and 3 valued at between $1,001 and $15,000. So if Trump has the maximum $15,000 in each of the trusts, he holds a stake in Sanofi that’s worth $1,485 — and, at the minimum, just $99.